Corneal Biomechanics in Glaucoma: Current Evidence for Diagnosis, Risk Stratification, and Prognosis Authors: Xian Wu, Hongbo Luo, Huanping Chen, Rui Luo Published: 2026 ABSTRACT AbstractBackgroundCorneal biomechanical measurements influence the interpretation of intraocular pressure and may also capture aspects of ocular-wall susceptibility that are not represented by central corneal thickness alone. Their diagnostic and prognostic relevance in glaucoma has therefore attracted increasing attention.MethodsA structured narrative search of PubMed/MEDLINE was performed from database inception through July 25, 2026, using combinations of terms related to glaucoma, ocular hypertension, corneal biomechanics, corneal hysteresis, the Ocular Response Analyzer, Corvis ST, dynamic Scheimpflug imaging, and emerging elastographic techniques. Reference lists of eligible publications and key reviews were also screened. Peer-reviewed clinical studies, systematic reviews, meta-analyses, authoritative reports, and selected foundational experimental studies were considered.Review FindingsThe Ocular Response Analyzer and Corvis ST provide device-specific measurements that are not directly interchangeable. Lower corneal hysteresis is consistently associated with glaucoma and with faster structural or functional progression, whereas the diagnostic performance of Corvis ST-derived parameters is more heterogeneous and varies by glaucoma subtype, intraocular pressure, central corneal thickness, axial length, and treatment exposure. Unlike previous broad overviews, this review explicitly separates diagnostic from prognostic evidence, contrasts findings across glaucoma phenotypes and devices, and examines the effect of major confounders. Brillouin microscopy and optical coherence elastography may eventually provide spatially resolved tissue measurements, but neither has been validated for routine glaucoma management.ConclusionCorneal biomechanical measurements should currently be regarded as complementary biomarkers rather than stand-alone diagnostic endpoints in glaucoma. Future progress will depend on standardized acquisition and reporting, subtype-specific prospective validation, and multimodal integration with structural and functional glaucoma assessments.Keywords: Corneal biomechanics, corneal hysteresis, ocular response analyzer, Corvis ST, glaucoma progression, ocular hypertension, risk stratification Introduction Glaucoma is a progressive optic neuropathy in which intraocular pressure (IOP) is the principal modifiable risk factor, but eyes exposed to similar IOP levels can show markedly different rates of damage. Corneal properties influence applanation-based IOP measurement, and central corneal thickness (CCT) is therefore routinely considered during clinical interpretation. However, thickness alone does not describe the time-dependent and load-dependent response of the cornea. In vivo biomechanical devices provide additional information about deformation, damping, and resistance to an applied air pulse.1–4 The potential relevance of corneal biomechanics extends beyond tonometric error. The cornea, sclera, and lamina cribrosa are collagen-rich tissues exposed to IOP-related loading. A corneal response indicating reduced damping or greater deformability may therefore be associated with a more compliant ocular-wall phenotype, although the cornea cannot be assumed to be a direct surrogate for the optic nerve head. Associations between lower corneal hysteresis (CH), lamina cribrosa displacement, retinal nerve fiber layer loss, and visual field progression support this hypothesis, but do not establish a causal pathway.5–9 Previous reviews have described ocular biomechanics broadly or focused primarily on CH. Important gaps remain regarding the comparability of device-derived parameters, differences among glaucoma subtypes, the influence of treatment and myopia, and the clinical maturity of newer Corvis ST indices. The present review addresses these gaps by separating diagnostic and prognostic evidence, comparing the Ocular Response Analyzer (ORA) with Corvis ST, and placing emerging technologies within the limits of current clinical validation. Review Methodology This article was prepared as a structured narrative review rather than a systematic review. PubMed was searched from database inception through July 25, 2026. The principal search concept combined glaucoma-related terms (“glaucoma”, ”ocular hypertension”, ”normal-tension glaucoma”, ”primary open-angle glaucoma”, ”angle-closure glaucoma” and “pseudoexfoliation glaucoma”) with biomechanical terms (“corneal biomechanics”, ”corneal hysteresis”, “corneal resistance factor”, ”Ocular Response Analyzer”, “Corvis ST”, ”dynamic Scheimpflug”, “biomechanical glaucoma factor”, “stress-strain index”, “Brillouin microscopy” and “optical coherence elastography”). Reference lists of eligible articles and key reviews were screened to identify additional studies. Eligible publications included peer-reviewed studies in humans evaluating the measurement principles, repeatability, diagnostic performance, risk stratification, or longitudinal prognostic value of corneal biomechanical parameters in glaucoma or ocular hypertension. Systematic reviews, meta-analyses, and authoritative evidence reports were included to contextualize consistency and evidence quality. Studies of corneal ectasia, refractive surgery, high myopia, or experimental biomechanics were included only when they clarified parameter construction, confounding, or emerging measurement technology. Case reports, non-peer-reviewed reports, and studies without relevant biomechanical outcomes were excluded. Titles and abstracts were screened for relevance, followed by full-text assessment of potentially eligible publications. Because the objective was interpretive synthesis rather than quantitative pooling, no formal risk-of-bias score or meta-analysis was performed. Principles and Clinically Used Devices for Corneal Biomechanical Assessment Ocular Response Analyzer The ORA uses a calibrated air pulse and an infrared electro-optical system to record two corneal applanation events. P1 is the air pressure at inward applanation, and P2 is the pressure at outward applanation during recovery. CH is calculated as P1 minus P2 and is interpreted as an empirical measure of viscous damping or energy dissipation during the bidirectional deformation cycle.1,2 The ORA also reports Goldmann-correlated IOP (IOPg), calculated from the mean of P1 and P2, and corneal-compensated IOP (IOPcc), a device-derived estimate designed to reduce cornea-related measurement effects. Corneal resistance factor (CRF) is derived from a weighted linear combination of P1 and P2 (commonly represented as P1 - kP2, with an empirically determined constant) and is intended to reflect overall corneal resistance to deformation. CRF is more strongly related to CCT than CH and should not be described as the “stiffness of CH” or as a direct material modulus.1,2,10 Mean CH values in healthy populations are commonly reported around 9.6–10.7 mmHg. In glaucoma, lower CH values are frequently observed, although interpretation should consider IOP and treatment status.3,4 Corvis ST Unlike the ORA, the Corvis ST (Corneal Visualization Scheimpflug Technology analyzer) combines a constant air pulse with high-speed Scheimpflug imaging to record the entire process of corneal deformation. The Corvis ST delivers a fixed-intensity air pulse (non-contact) and captures the corneal deformation process over approximately 31 ms at a speed of 4330 frames per second, obtaining 140 consecutive images. The device has a built-in autofocus system that can precisely align with the corneal center. Each measurement process is similar, consisting of three phases: the first applanation (A1), reaching maximum concavity, and the second applanation (A2).11 Corvis ST output includes deformation amplitude (DA), highest concavity radius (HCR), applanation times and velocities, peak distance (PD), deformation amplitude ratio (DAR), stiffness parameter at first applanation (SP-A1), and stress-strain index (SSI). Biomechanically corrected intraocular pressure (bIOP) is intended to be less dependent on CCT and selected corneal properties than conventional tonometry, but it remains a device-specific estimate rather than a direct intracameral pressure measurement.12 In addition, the Corvis ST can provide measurements of central corneal thickness and intraocular pressure, and by analyzing the dynamic corneal deformation process, it calculates the bIOP. Compared with the traditional Goldmann applanation tonometer, this parameter may provide a less cornea-dependent estimate of IOP in selected clinical settings.13 Most parameters obtained by the Corvis ST show good repeatability.14,15 It has been applied in glaucoma screening, keratoconus diagnosis, refractive surgery evaluation, and other fields.16,17 In recent years, Corvis ST has also incorporated several model-derived or composite parameters, including the stiffness parameter at first applanation (SP-A1), stress-strain index (SSI), and Corvis Biomechanical Index (CBI). In addition, the Tomographic and Biomechanical Index (TBI) integrates Scheimpflug-based corneal tomographic and biomechanical data and was developed primarily to improve the detection of corneal ectasia. Therefore, CBI and TBI should not be regarded as established glaucoma biomarkers. By contrast, the Biomechanical Glaucoma Factor (BGF) was specifically developed for glaucoma discrimination, although its clinical and prognostic utility remains under investigation.4,18 In summary, ORA and Corvis ST, as the two corneal biomechanical assessment devices commonly used in clinical practice, each have distinct technical characteristics. The ORA primarily obtains empirical indices such as CH and CRF through measurement, whereas the Corvis ST can completely record the dynamic deformation process of the cornea and provide multiple quantitative parameters. Because of fundamental differences in their measurement principles and the ways their parameters are constructed, their measurement results are generally not directly comparable or interchangeable.11 Key Parameters and Their Clinical Interpretation CH and CRF are correlated ORA-derived indices but capture different weighted features of the same bidirectional pressure signal. CH is generally treated as a damping-related metric, whereas CRF represents overall resistance to air-pulse deformation and has a stronger relationship with CCT. Neither is a direct measurement of Young’s modulus, scleral stiffness, or lamina cribrosa mechanics.1,2,4,19 Repeated definitions have therefore been avoided in the sections below; subsequent discussion uses the abbreviations consistently. Corvis ST parameters describe different stages of the deformation response. Larger DA or DAR, smaller HCR, faster inward movement, or lower SP-A1 may indicate greater deformability under a given loading condition. However, the observed response is jointly determined by tissue properties, IOP-related prestress, geometry, CCT, and measurement conditions.12,20,21 SSI was developed to estimate material stiffness with reduced dependence on IOP and CCT, but evidence supporting its value in glaucoma remains limited. Definitions and the current glaucoma relevance of principal Corvis ST outputs are summarized in Table 1. Table 1Definitions, Biomechanical Interpretation, and Current Glaucoma Relevance of Principal Corvis ST ParametersParameterAbbreviationDefinitionBiomechanical InterpretationReported Glaucoma Relevance and LimitationsDeformation amplitudeDAMaximum apical displacement at highest concavity.Larger values indicate greater air-pulse deformation.Sometimes larger in glaucoma or high myopia; strongly dependent on IOP, CCT, and geometry, with inconsistent independent value.Highest concavity radiusHCRRadius of curvature at maximum concavity.A smaller radius indicates a more curved, deformable response.Reported group differences often weaken after IOP/CCT adjustment; no stand-alone threshold.First applanation timeA1TTime from air-pulse onset to first inward applanation.Timing of inward deformation; sensitive to prestress.Strong IOP dependence; limited independent association with severity.Second applanation timeA2TTime from air-pulse onset to second applanation during recovery.Timing of recovery after highest concavity.Findings differ by treatment status; no validated threshold.First applanation velocityA1VCorneal velocity at first applanation.Speed of inward movement.Occasional association with visual field severity; inconsistent and IOP-dependent.Second applanation velocityA2VCorneal velocity at second applanation.Speed of outward recovery.Limited heterogeneous evidence; interpret with other variables.Time to highest concavityHCTTime required to reach maximum concavity.Time-dependent deformation response.Little evidence of independent glaucoma value.Peak distancePDDistance between the two corneal peaks at highest concavity.Horizontal deformation configuration.May be higher in high myopia; glaucoma value is uncertain and geometry-dependent.Deformation amplitude ratioDARRatio comparing apical deformation with deformation at peripheral reference points.Relative spatial deformation profile.Associated with severity in some untreated POAG cohorts; inconsistent after treatment.Stiffness parameter at first applanationSP-A1Adjusted first-applanation pressure divided by apical deflection.Higher values indicate greater deformation resistance.Cross-sectional evidence only; loading-dependent and without a prognostic threshold.Stress-strain indexSSIModel-derived material-stiffness estimate with reduced IOP/CCT dependence.Approximates nonlinear corneal material behavior.Promising for separating material from loading effects; prospective glaucoma evidence is limited.Biomechanically corrected IOPbIOPDevice-derived IOP estimate adjusted by age, CCT, and dynamic response.Pressure estimate, not a biomechanical biomarker.May supplement tonometry in altered corneas; device-specific and not intracameral IOP.Biomechanical glaucoma factorBGFComposite of selected dynamic-response variables and bIOP.Classifier developed for glaucoma discrimination.Moderate NTG discrimination but poorer treated-POAG performance; needs external prospective validation.Notes: The parameters are device-derived and are affected by IOP-related prestress, CCT, geometry, age, myopia, and treatment. Reported clinical associations are based mainly on cross-sectional studies and do not establish diagnostic or prognostic thresholds.7,15,22–26.Abbreviations: CCT, central corneal thickness; IOP, intraocular pressure; NTG, normal-tension glaucoma; POAG, primary open-angle glaucoma. Definitions, Biomechanical Interpretation, and Current Glaucoma Relevance of Principal Corvis ST Parameters Notes: The parameters are device-derived and are affected by IOP-related prestress, CCT, geometry, age, myopia, and treatment. Reported clinical associations are based mainly on cross-sectional studies and do not establish diagnostic or prognostic thresholds.7,15,22–26. Abbreviations: CCT, central corneal thickness; IOP, intraocular pressure; NTG, normal-tension glaucoma; POAG, primary open-angle glaucoma. Glaucoma-Related Clinical Evidence Cross-Sectional Diagnosis and Risk Stratification Cross-sectional studies generally report lower CH in several glaucoma phenotypes than in healthy eyes. A systematic review and meta-analysis confirmed lower CH in primary open-angle glaucoma (POAG), including relevant subtype analyses, compared with normal controls. Lower CH has also been reported in individual studies of normal-tension glaucoma (NTG), primary angle-closure glaucoma, and pseudoexfoliation glaucoma, although the magnitude of these differences varies across studies.19,22 Lower CH is also observed in some eyes with ocular hypertension that later develops visual field loss. These findings support a risk association, but overlapping distributions prevent CH from functioning as a stand-alone diagnostic test. For example, Rojananuangnit analyzed 894 glaucoma patients and found that the mean CH was significantly lower in high-tension primary open-angle glaucoma (POAG-HTG) than in NTG and ocular hypertension (OHT), and among patients with POAG-HTG and primary angle-closure glaucoma (PACG), those with more severe disease had lower CH. Another comparative study showed that CH in patients with pseudoexfoliation glaucoma (PXG) was also lower than that in POAG and normal subjects. In addition, factors such as age and diabetes have an influence on CH, and therefore adjustments should be made during analysis.4,23 More importantly, the CH value has been demonstrated to be closely associated with structural damage and functional progression in glaucoma. A multicenter prospective study showed that CH was significantly positively correlated with optic disc retinal nerve fiber layer (RNFL) thickness, while negatively correlated with the cup-to-disc ratio.24 Structural and Functional Progression Longitudinal evidence is strongest for CH. In a prospective cohort, each 1 mmHg lower baseline CH was associated with approximately 0.25% per year faster decline in visual field index, and the influence of IOP on progression was greater in eyes with lower CH.25 Studies have further found that lower CH values are closely associated with a faster rate of retinal nerve fiber layer loss and optic disc microvascular damage. A prospective follow-up study conducted by Susanna et al on 287 individuals at high risk for glaucoma showed that those who eventually progressed to glaucoma had significantly lower baseline CH values than those who did not progress (9.5 mmHg vs 10.2 mmHg); moreover, each 1 mmHg decrease in baseline CH was associated with a 21% increased risk of converting to glaucoma.5,25,27 Subsequent studies have linked lower CH with faster central visual field loss, retinal nerve fiber layer thinning, and microvascular loss, although effect sizes vary and some associations are small after multivariable adjustment.5,9 Longitudinal change in CRF may also be associated with visual field progression, but this evidence is less extensive and may reflect changes in IOP, age, or treatment over time.26 Taken together, these findings support CH as an independent prognostic marker associated with glaucoma progression in several longitudinal cohorts. Conflicting Findings and Sources of Heterogeneity Several factors may explain the heterogeneity of findings across studies. First, the ORA and Corvis ST use different loading profiles and detection systems; therefore, similarly described concepts such as damping, resistance, and stiffness are not numerically interchangeable across devices. Second, IOP influences the prestressed state of the cornea and consequently affects the measured deformation response. Third, CCT, age, corneal curvature, axial length, diabetes, high myopia, refractive surgery, and topical therapy may independently influence biomechanical measurements. Finally, studies differ in glaucoma subtype, disease severity, treatment exposure, ethnicity, and statistical handling of data from one or both eyes.4,12,28–31 High myopia illustrates this complexity. Highly myopic eyes may demonstrate larger deformation amplitude, peak distance, or other features suggestive of greater deformability; however, these differences are also associated with axial length, corneal geometry, and IOP. Because high myopia is itself associated with glaucoma risk and can complicate structural assessment, an observed corneal biomechanical parameter may represent a confounder, a correlated phenotype, or a true susceptibility marker. Current observational evidence does not fully distinguish among these possibilities.28–30 The inconsistent associations between Corvis ST parameters and visual field indices also warrant caution. Some studies in untreated glaucoma have reported relationships between deformation amplitude ratio or applanation velocity and visual field severity, whereas weaker associations have been observed in treated cohorts. Differences in IOP range and medication exposure may partly explain these discrepancies. Future prospective studies should therefore report baseline and longitudinal IOP, treatment changes, CCT, axial length, and device software version, and should prespecify analyses according to glaucoma subtype.32–34 Potential Biomechanical Links to Glaucomatous Susceptibility A plausible, but incompletely proven, model is that lower corneal damping accompanies a more compliant ocular-wall phenotype. Under transient or chronic IOP loading, a more deformable sclera-lamina cribrosa complex could undergo greater strain, altering axonal transport and the microenvironment of retinal ganglion cell axons. The observed association between lower CH and greater anterior lamina cribrosa displacement during IOP change is consistent with this model.6 Nevertheless, CH is measured in the anterior segment and cannot directly quantify posterior scleral or laminar material properties. Corneal and posterior-segment biomechanics may also share systemic or age-related determinants of collagen organization, extracellular matrix turnover, and tissue hydration. High myopia involves scleral remodeling and altered globe geometry, while aging can increase some measures of material stiffness yet reduce damping-related responses.28,30 These relationships are complex and may be nonlinear. The mechanistic section should therefore be interpreted as hypothesis-generating rather than evidence that corneal measurements causally mediate optic nerve damage. Treatment further complicates mechanistic inference. Prostaglandin analogues can influence matrix metalloproteinase expression and scleral permeability in experimental systems, and clinical studies report changes in corneal biomechanical measurements during long-term therapy.31,35,36 Such findings may represent drug effects, IOP lowering, or both. Longitudinal studies with treatment-naive baselines and repeated measurements are required to separate these effects. Clinical Application and Limitations Among currently available metrics, CH has the most mature evidence for adjunctive risk assessment. A low CH may increase concern when structural and functional findings are borderline, when progression occurs despite apparently acceptable clinic IOP, or when deciding how intensively to monitor a glaucoma suspect. However, no universally accepted CH threshold defines glaucoma, and evidence does not support treating CH itself as a therapeutic target.7–9,27 bIOP and IOPcc can supplement conventional tonometry, particularly when corneal geometry has been altered by refractive surgery, but they should be interpreted within the device-specific measurement framework.13,16,37 Newer Corvis ST parameters may add phenotypic information, yet BGF, SSI, SP-A1, and DAR lack sufficiently consistent prospective evidence to determine treatment intensity or predict individual progression in routine practice. Major limitations include incomplete standardization, software-version dependence, noninterchangeability across devices, and confounding by IOP, CCT, age, axial length, myopia, corneal surgery, diabetes, and medication exposure. Many studies are cross-sectional, single-center, or include treated populations with heterogeneous disease. Diagnostic accuracy estimates may also be inflated when derivation and validation samples are similar. Corneal biomechanics should therefore be integrated with optic nerve imaging, retinal nerve fiber layer and ganglion cell analysis, gonioscopy, visual fields, and longitudinal IOP data rather than used in isolation. Emerging Technologies and Future Research Directions Brillouin microscopy uses the frequency shift of scattered light to generate spatially resolved estimates related to the longitudinal elastic modulus. Foundational work demonstrated three-dimensional mapping of corneal mechanical contrast, and recent clinical-device studies have improved motion tracking, repeatability, and reproducibility.38,39 However, the Brillouin shift is influenced by hydration and is not directly equivalent to Young’s or shear modulus. Glaucoma-specific normative ranges, posterior-segment coupling, and prognostic validity have not been established. Optical coherence elastography (OCE) estimates tissue mechanics by imaging the propagation of mechanically induced waves. Recent in vivo work has demonstrated spatial variation in human corneal shear modulus.40 OCE offers high spatial and temporal resolution, but results depend on the excitation method, wave model, tissue anisotropy, and IOP-related prestress. At present, it remains a research technology rather than a clinical glaucoma test. Future studies should prioritize harmonized acquisition and reporting, prospective enrollment of treatment-naive and well-characterized glaucoma subtypes, external validation across ethnic groups and devices, and longitudinal models that adjust for time-varying IOP and medication exposure. Multimodal prediction models should test whether biomechanical measurements improve calibration and discrimination beyond established structural and functional predictors. The clinically relevant question is not whether a parameter differs statistically between groups, but whether it provides reproducible incremental information that changes patient management or improves outcomes. Conclusion Corneal biomechanics adds a useful but indirect dimension to glaucoma assessment. Lower CH is consistently associated with glaucoma and has the strongest longitudinal evidence for faster structural or functional progression. Corvis ST provides a richer description of dynamic corneal deformation, but individual and composite parameters show heterogeneous performance across glaucoma subtypes and treatment settings. CBI and TBI are ectasia-oriented indices, while BGF remains an investigational glaucoma-specific composite rather than an established clinical endpoint. Corneal biomechanical measurements should therefore complement, not replace, IOP assessment, optic nerve and retinal imaging, and visual field testing. Progress toward routine implementation will require standardized methods, prospective subtype-specific validation, and demonstration of incremental clinical utility. Disclosure The authors report no conflicts of interest. References